Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173,063 | 95,823 | 56,221 | 45,586 | 54,090 |
| Marketable Securities | 64,698 | 41,966 | 44,556 | 44,779 | 49,154 |
| Receivables | 20,302 | 15,443 | 12,704 | 11,717 | 7,047 |
| Inventories | 9,227 | 5,673 | 4,325 | 4,832 | 1,964 |
| TOTAL | $276,135 | $169,186 | $128,907 | $114,390 | $115,619 |
| Non-Current Assets | |||||
| PPE Net | 655 | 689 | 1,297 | 1,967 | 2,046 |
| Investments And Advances | 5,022 | 4,502 | 0 | 675 | 1,893 |
| Other Non-Current Assets | 3,899 | 3,934 | 5,415 | 2,714 | 2,447 |
| TOTAL | $9,576 | $9,125 | $6,712 | $5,356 | $6,386 |
| Total Assets | $285,711 | $178,311 | $135,619 | $119,746 | $122,005 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,431 | 16,538 | 12,383 | 12,102 | 10,023 |
| Accrued Expenses | 10,570 | 10,814 | 8,257 | 6,948 | 9,554 |
| Other current liabilities | 7,948 | 3,860 | 3,276 | 3,330 | 1,859 |
| TOTAL | $45,949 | $31,212 | $23,916 | $22,380 | $21,436 |
| Non-Current Liabilities | |||||
| Long Term Debt | 121,734 | 98,551 | 97,537 | N/A | N/A |
| Other Non-Current Liabilities | 126,831 | 113,760 | 103,527 | 88,953 | 4,214 |
| TOTAL | $248,565 | $212,311 | $201,064 | $88,953 | $4,214 |
| Total Liabilities | $294,514 | $243,523 | $224,980 | $111,333 | $25,650 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,094 | 34,122 | 23,441 | 22,668 | 22,273 |
| Common Shares | 115 | 89 | 63 | 61 | 60 |
| Retained earnings | -806,222 | -679,348 | -577,104 | -467,321 | -356,501 |
| Other shareholders' equity | 56 | 12 | -107 | -25 | 271 |
| TOTAL | $-8,803 | $-65,212 | $-89,361 | $8,413 | $96,355 |
| Total Liabilities And Equity | $285,711 | $178,311 | $135,619 | $119,746 | $122,005 |